Also, FDA is proposing two other limitations within the submission of the supplemental PMTA. Below proposed § 1114.15(a), a supplemental PMTA couldn't be submitted where by the advertising and marketing purchase for the initial tobacco product is withdrawn or has long been briefly suspended or is th